FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308739639> ?p ?o ?g. }

• W4308739639 endingPage "487" @default.
• W4308739639 startingPage "464" @default.
• W4308739639 abstract "Pompe disease is a rare genetic neuromuscular disorder caused by acid α-glucosidase (GAA) deficiency resulting in lysosomal glycogen accumulation and progressive myopathy. Enzyme replacement therapy, the current standard of care, penetrates poorly into the skeletal muscles and the peripheral and central nervous system (CNS), risks recombinant enzyme immunogenicity, and requires high doses and frequent infusions. Lentiviral vector-mediated hematopoietic stem and progenitor cell (HSPC) gene therapy was investigated in a Pompe mouse model using a clinically relevant promoter driving nine engineered GAA coding sequences incorporating distinct peptide tags and codon optimizations. Vectors solely including glycosylation-independent lysosomal targeting tags enhanced secretion and improved reduction of glycogen, myofiber, and CNS vacuolation in key tissues, although GAA enzyme activity and protein was consistently lower compared with native GAA. Genetically modified microglial cells in brains were detected at low levels but provided robust phenotypic correction. Furthermore, an amino acid substitution introduced in the tag reduced insulin receptor-mediated signaling with no evidence of an effect on blood glucose levels in Pompe mice. This study demonstrated the therapeutic potential of lentiviral HSPC gene therapy exploiting optimized GAA tagged coding sequences to reverse Pompe disease pathology in a preclinical mouse model, providing promising vector candidates for further investigation. Pompe disease is a rare genetic neuromuscular disorder caused by acid α-glucosidase (GAA) deficiency resulting in lysosomal glycogen accumulation and progressive myopathy. Enzyme replacement therapy, the current standard of care, penetrates poorly into the skeletal muscles and the peripheral and central nervous system (CNS), risks recombinant enzyme immunogenicity, and requires high doses and frequent infusions. Lentiviral vector-mediated hematopoietic stem and progenitor cell (HSPC) gene therapy was investigated in a Pompe mouse model using a clinically relevant promoter driving nine engineered GAA coding sequences incorporating distinct peptide tags and codon optimizations. Vectors solely including glycosylation-independent lysosomal targeting tags enhanced secretion and improved reduction of glycogen, myofiber, and CNS vacuolation in key tissues, although GAA enzyme activity and protein was consistently lower compared with native GAA. Genetically modified microglial cells in brains were detected at low levels but provided robust phenotypic correction. Furthermore, an amino acid substitution introduced in the tag reduced insulin receptor-mediated signaling with no evidence of an effect on blood glucose levels in Pompe mice. This study demonstrated the therapeutic potential of lentiviral HSPC gene therapy exploiting optimized GAA tagged coding sequences to reverse Pompe disease pathology in a preclinical mouse model, providing promising vector candidates for further investigation." @default.
• W4308739639 created "2022-11-15" @default.
• W4308739639 creator A5004926752 @default.
• W4308739639 creator A5006433618 @default.
• W4308739639 creator A5009396611 @default.
• W4308739639 creator A5020619787 @default.
• W4308739639 creator A5025979196 @default.
• W4308739639 creator A5029232539 @default.
• W4308739639 creator A5033139713 @default.
• W4308739639 creator A5034146947 @default.
• W4308739639 creator A5054362291 @default.
• W4308739639 creator A5068937669 @default.
• W4308739639 creator A5074142123 @default.
• W4308739639 creator A5074750796 @default.
• W4308739639 creator A5079599454 @default.
• W4308739639 creator A5082187481 @default.
• W4308739639 creator A5086481665 @default.
• W4308739639 date "2022-12-01" @default.
• W4308739639 modified "2023-10-18" @default.
• W4308739639 title "Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease" @default.
• W4308739639 cites W175813982 @default.
• W4308739639 cites W1893315106 @default.
• W4308739639 cites W1971873142 @default.
• W4308739639 cites W1975795658 @default.
• W4308739639 cites W1976251943 @default.
• W4308739639 cites W1976329054 @default.
• W4308739639 cites W1977495823 @default.
• W4308739639 cites W1979145911 @default.
• W4308739639 cites W1981137015 @default.
• W4308739639 cites W1986484885 @default.
• W4308739639 cites W1986979860 @default.
• W4308739639 cites W1993669797 @default.
• W4308739639 cites W1994468264 @default.
• W4308739639 cites W1996788733 @default.
• W4308739639 cites W2014115203 @default.
• W4308739639 cites W2019926561 @default.
• W4308739639 cites W2032796670 @default.
• W4308739639 cites W2035445362 @default.
• W4308739639 cites W2042974652 @default.
• W4308739639 cites W2052766943 @default.
• W4308739639 cites W2058352256 @default.
• W4308739639 cites W2061452528 @default.
• W4308739639 cites W2064921107 @default.
• W4308739639 cites W206621073 @default.
• W4308739639 cites W2069679318 @default.
• W4308739639 cites W2073643492 @default.
• W4308739639 cites W2075594211 @default.
• W4308739639 cites W2076860206 @default.
• W4308739639 cites W2079474257 @default.
• W4308739639 cites W2082991267 @default.
• W4308739639 cites W2089319449 @default.
• W4308739639 cites W2089713475 @default.
• W4308739639 cites W2092433968 @default.
• W4308739639 cites W2092683416 @default.
• W4308739639 cites W2095643828 @default.
• W4308739639 cites W2098331662 @default.
• W4308739639 cites W2110978695 @default.
• W4308739639 cites W2117675141 @default.
• W4308739639 cites W2120584824 @default.
• W4308739639 cites W2121309530 @default.
• W4308739639 cites W2127608615 @default.
• W4308739639 cites W2133059825 @default.
• W4308739639 cites W2133285286 @default.
• W4308739639 cites W2141570423 @default.
• W4308739639 cites W2141890696 @default.
• W4308739639 cites W2159121677 @default.
• W4308739639 cites W2526056229 @default.
• W4308739639 cites W2574524657 @default.
• W4308739639 cites W2618968334 @default.
• W4308739639 cites W2620901688 @default.
• W4308739639 cites W2748941940 @default.
• W4308739639 cites W2753217443 @default.
• W4308739639 cites W2753413345 @default.
• W4308739639 cites W2764213443 @default.
• W4308739639 cites W2770869187 @default.
• W4308739639 cites W2774819103 @default.
• W4308739639 cites W2790245192 @default.
• W4308739639 cites W2803597823 @default.
• W4308739639 cites W2805769253 @default.
• W4308739639 cites W2903654923 @default.
• W4308739639 cites W2912990441 @default.
• W4308739639 cites W2940078382 @default.
• W4308739639 cites W2940995888 @default.
• W4308739639 cites W2942722183 @default.
• W4308739639 cites W2944148921 @default.
• W4308739639 cites W2945099352 @default.
• W4308739639 cites W2947446269 @default.
• W4308739639 cites W2947999169 @default.
• W4308739639 cites W2950988568 @default.
• W4308739639 cites W2953110388 @default.
• W4308739639 cites W2970911162 @default.
• W4308739639 cites W2988026289 @default.
• W4308739639 cites W2990054379 @default.
• W4308739639 cites W2999048613 @default.
• W4308739639 cites W3006279252 @default.
• W4308739639 cites W3016405424 @default.
• W4308739639 cites W3021798323 @default.
• W4308739639 cites W3024470836 @default.

• next